Please activate JavaScript!
Please install Adobe Flash Player, click here for download

EH 1_2015

| visit us onfollow us on European Hospital Verlags GmbH | Theodor-Althoff-Straße 45 | 45133 Essen www.healthcare-in-europe.com Trends & innovations in healthcare. 25 YEARS of European healthcare communication: print & online. Online Portal | Newspaper | Product Guides | Newsletter Stay tuned on all channels. al ers tions, qually Shimadzu_RADbook_2013.qxd 07.02.2013 13:33 Uhr Seite 1 RADBOOK2012·TheRadiologyGuidetoTechnology&InformaticsinEurope W IT W CT W MRI W Interventional W Mammo W R / F W Nuc W Displays / Printers W Ultrasound W Injectors W Testing Devices The Radiology Guide to Technology & Informatics in Europe T 19.- 2013 The world’s most advanced dynamic volume CT just got even better. The new Aquilion ONE ViSION Edition provides you and your patients robust clinical solutions when you need them most. This innovative Dynamic Volume CT enables all patients a successful examination, with the lowest possible radiation exposure and the highest quality diagnostic outcomes. For more information please turn to page 12 or visit www.aquilionvision.com. RADBOOK2014 The Radiology Guide to Technology and Informatics in Europe T19.- Shimadzu_RADbo ok_2013.qxd 07.02.2013 13:33 Uhr Seite 1 RADBOOK2012·TheRadiologyGuidetoTechnology&InformaticsinEurope W IT W CT W MRI W Interventional W Mammo W R / F W Nuc W Displays / Printers W Ultrasound W Injectors W Testing Devices The Radiology Guide to Technology & Informatics in Europe T 19.- 2013 The world’s most advanced dynamic volume CT just got even better. The new Aquilion ONE ViSION Edition provides you and your patients robust clinical solutions when you need them most. This innovative Dynamic Volume CT enables all patients a successful examination, with the lowest possible radiation exposure and the highest quality diagnostic outcomes. For more information please turn to page 12 or visit www.aquilionvision. com. IT CT MRI Interventional Mammo R/F Nuc Displays/Printers Ultrasound Injectors TestingDevices Villa Sistemi Medicali’s new general radiographic system, the Moviplan iC, has been conceived for every diagnostic need. It is available in a wide range of configurations, from basic analog versions up to fully digital and automatized rooms. THE EUROPEAN FORUM FOR THOSE IN THE BUSINESS OF MAKING HEALTHCARE WORK CONTENTS NEWS & MANAGEMENT 1-3 ONCOLOGY 4-5 RADIOLOGY 6-8 MEDICA PRODUCTS 9 INFECTION CONTROL 10 LABORATORY 11-16 www.european -hospital.com V O L 2 3 I S S U E 6 / 1 4 • D E C E M B E R 2 0 1 4 Report: Michael Krassnitzer By definition, an emerging infec- tious disease is one that has newly appeared in a population or has been known for some time but is rapidly increasing in incidence or spreading to new geographic areas. At the International Meeting on Emerging Diseases and Surveillance (IMED 2014), in Vienna, this year’s focus was on one particular emerg- ing infectious disease: Ebola. According to the World Health Organisation (WHO) in the recent outbreak 5,400 people have died of this dangerous disease and, as of 20 November 2014, more than 15,000 cases were reported in eight countries. ‘This most serious Ebola outbreak ever was caused by social, geo- graphic and political factors in the regions affected,’ says Belgian physi- cian Hilde De Clerck MD, who works for the aid organisation Médecins sans frontières in the crisis regions. All severely affected countries are poor, have underdeveloped health systems, were involved in wars or armed conflicts in the past few years, and the people tend to mis- trust government agencies and the countries mistrust each other. De Clerck: ‘The epidemic start- ed off slowly and spread quick- ly, affecting people from all walks of life. Lack of awareness about the disease, insufficient protection measures and the high degree of mobility of the people between three of the countries concerned – be it for business or family purposes – contributed to Ebola being able acute Ebola infection cannot travel. During the severe acute respira- tory syndrome (SARS) pandemic, in 2002/2003, 45 million travellers were screened at airports – with only a single SARS case being iden- tified. It is much more important, according to the experts, to use the money for aid programmes right in the affected regions. ‘It is crucial to provide help where the epi- demic broke out, that is in Western Africa,’ underlines Jack Woodall MA PhD, an epidemiologist from Brazil and vice-editor of ProMED- mail, the web-based Programme for Monitoring Emerging Diseases of the International Society for Infectious Diseases (ISID). He is confident: ‘We can stop the disease from spreading if we manage to break the chain of infection.’ to spread.’ There is, however, good news: Oyewale Tomori DVM, PhD, President of the Nigerian Academy of Science, describes how Ebola was contained in his country. On 20 July 2014 a person from Liberia with acute Ebola symptoms arrived at Lagos International Airport. The preliminary diagnosis – Ebola – was confirmed by a private hospital. This index case had had contact with 72 people at the airport and in the hos- pital, who potentially were exposed to the virus. The Ministry of Health and the Nigeria Centre for Disease Control (NCDC) declared an Ebola emer- gency. On 23 July the Ministry of Health, the regional government of Lagos and international partners set up an Ebola crisis intervention centre. The index case died on 25 July 20. Subsequent Ebola infections were reported in Nigeria. All of them could be traced back to the index case. Close to 900 identified con- tact persons were monitored; eight patients died. On 20 October 2014, WHO officially declared Nigeria Ebola-free. ‘It is to a large extent due to the quickly established crisis inter- vention centre that we were able to successfully fight the disease,’ said Tomori. ‘We not only suf- fer from a real epidemic in West Africa, we are also suffering from an epidemic of fear that’s spread- ing all over the globe,’ said Dr Pamela Rendi-Wagner, Director of the Department of Public Health Services and Medical Affairs at the Austrian Federal Ministry of Health and adds, ‘Despite concerted efforts by all public health authorities it is difficult to counter the rising public panic’. In Austria it was reported that several health professionals quit their jobs because they feared hav- ing to care for Ebola patients. ‘It is our main task to listen to these fear-driven concerns and to inform and communicate widely, openly, early and in a transparent fashion in order to create trust,’ the health official emphasised. Experts agree on one issue: they consider screening of in-coming travellers at international airports for Ebola to be useless, inter alia because usually people with an Ebola: Reports of panic among medics Experts confirm the disease can be contained by stopping the chain of infection Médecins Sans Frontières medics: a vital aid organisation in crisis zones Source:MSF;JulienRey RADIOLOGY 6-8 • Precision radiotherapy with 4-D imaging • MorphMatch technology for 3-T scans LABORATORY 11-16 • Breakthrough in hepatitis C research • Stain-free 3-D digital pathology • Recycling blood lost during surgery EUROPEAN HOSPITAL  Vol 24 Issue 1/15 32 INTENSIVE CARE Report: Chrissanthi Nikolakudi ‘In 2014, we restructured Philips into two strong companies,’ Arne Cohrs explains. ‘One focuses on healthcare, the other on lighting. It’s our ambition to make the world healthier and more sustainable with our innovations – that is from the patient’s room to the living room, starting with healthy living, preven- tion, diagnosis and treatment. This is where ventilation comes in. To realise our vision we merged the former consumer lifestyle segment and our healthcare segment. Here, ventilation is a key element, offer- ing a respiratory solution for home and hospital care. With our launch of Respironics V680 we built upon experience and expertise in non- invasive ventilation to develop a non-invasive ventilator with invasive modes.’ Whilst Philips sells the V200 pre- mium ventilator applying invasive ventilation with non-invasive func- tions, the V680 ventilator brings both together in one device. In the non-invasive part the firm improved monitoring in the V680, he explains. ‘The device now carries loops in non-invasive. We also included dynamic measurements, such as dynamic elastin’s resistance compli- ance. These are great tools and an important next step for us. Asynchrony between the patient and ventilator: ‘For the V680 we shortened the trigger delay and achieve the best flow wave,’ he explains. That con- cept is based on the centrifuge com- pressor hardware and on Auto-Trak software. ‘The V680 features Auto-Trak Plus, a very accurate combination of several algorithms that automati- cally take care of the asynchrony that normally can be seen espe- cially in non-invasive ventilation. The user doesn’t have to set the trigger because Auto-Trak Plus is automatically active while a positive wearable leak – always present in non-invasive ventilation – can be compensated. We compensate up to 70 leaks per minute. Of course, one of the biggest questions is how to make a good model for the patient. The answer is a concept based on the centrifugal compressor and on Auto-Trak Plus.’ ‘The compensation is one of the biggest achievements of the V680. Of course it’s built on our outstand- ing experience with non-invasive. To synchronise with the patient, to really deal with the presence of a leak, which you always have, is to apply mass ventilation.’ Trauma care: ‘We are addressing highly acute patients. A ventilator needs state- of-the-art non-invasive and invasive capabilities, as in the V680. The set-up must be quick and easy, and so must the switch between non- invasive and invasive. Moreover, the unit must be easy and intuitive to use and needs a reliable battery to ensure energy supply for a couple of hours. This is just as important as the turbine and blower, because then you can apply high pressure. ‘In trauma care in the past, non- invasive ventilation was normally used as a preventive and thera- py tool to manage highly acute patients. Intubation increases the risk of developing ventilator-associ- ated injuries. Non-invasive ventila- tion accelerates post-surgical recov- ery, as long as the right pressures and improved oxygenation are used. This is especially valid for trauma patients.’ Trends: ‘Recent trends go towards auto- matic modes, closed loop ventila- tion, weaning mode. We also see an overall trend towards more non- invasive efforts before intubating a patient, but obviously you want to avoid possible side effects, such as infection rates going up; so auto- matic modes, such as loop, are increasing, especially dedicated to the weaning process. The future: ‘Ventilation will play an important role in the future. Philips will con- tinue to invest. We want to be the partner of choice for customers and the ICUs dealing with high acute patients. ‘With our mass portfolio in home and hospital ventilation, the future links very well with our overall strategy for Philips worldwide. Two in oneThe recently launched Respironics V680 ventilator, from Philips Healthcare EMEA, was guided onto the market by Arne Cohrs, its Sales and Marketing Director of Therapeutic Care in Patient Care and Monitoring. We asked him about his department and the merits of non-invasive and invasive ventilators Arne Cohrs, Sales and Marketing Director of Therapeutic Care, Patient Care and Clinical Informatics at Philips Healthcare EMEA V O L 23 I S S U E 6 / 14 • D E C E M B E R 2014

Pages Overview